{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:45:26Z","timestamp":1780436726892,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jpurol.2013.12.017","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T14:46:24Z","timestamp":1389969984000},"page":"753-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Single center experience with oxybutynin transdermal system (patch) for management of symptoms related to non-neuropathic overactive bladder in children: An attractive, well tolerated alternative form of administration"],"prefix":"10.1016","volume":"10","author":[{"given":"Joseph M.","family":"Gleason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Koyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius J.","family":"B\u00e4gli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao L.","family":"Pippi Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando J.","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2013.12.017_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.ju.0000147813.28822.d2","article-title":"Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction","volume":"173","author":"Franco","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2013.12.017_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1464-410X.2009.09129.x","article-title":"Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: results of a multicentre observational cohort study","volume":"106","author":"Alloussi","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2013.12.017_bib3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00003495-200464080-00011","article-title":"Oxybutynin extended-release: a review of its use in the management of overactive bladder","volume":"64","author":"Siddiqui","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jpurol.2013.12.017_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.urology.2006.04.034","article-title":"Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin","volume":"68","author":"Van Arendonk","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2013.12.017_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MOU.0b013e32833aa185","article-title":"New strategies for medical management of overactive bladder in children","volume":"20","author":"Schr\u00f6der","year":"2010","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.jpurol.2013.12.017_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-5347(05)64115-8","article-title":"Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence","volume":"169","author":"Reinberg","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2013.12.017_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0090-4295(01)01569-2","article-title":"Preliminary study of the safety and efficacy of extended-release oxybutynin in children","volume":"59","author":"Youdim","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2013.12.017_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0009922806292786","article-title":"Pill swallowing ability and training in children 6 to 11 years of age","volume":"45","author":"Meltzer","year":"2006","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.jpurol.2013.12.017_bib9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0022-5347(01)65629-5","article-title":"Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia","volume":"156","author":"Painter","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2013.12.017_bib10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.juro.2008.05.056","article-title":"Intravesical oxybutynin for children with poorly compliant neurogenic bladder: a systematic review","volume":"180","author":"Guerra","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2013.12.017_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0022-5347(05)64684-8","article-title":"Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence","volume":"168","author":"Dmochowski","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2013.12.017_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0090-4295(03)00356-X","article-title":"Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence","volume":"62","author":"Dmochowski","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2013.12.017_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/17425255.3.3.435","article-title":"Transdermal oxybutynin: a review","volume":"3","author":"Shaw","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jpurol.2013.12.017_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003495-200969030-00008","article-title":"Transdermal oxybutynin","volume":"69","author":"Baldwin","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jpurol.2013.12.017_bib15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.juro.2009.06.058","article-title":"Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity","volume":"182","author":"Cartwright","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2013.12.017_bib16","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.juro.2008.11.125","article-title":"Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study","volume":"181","author":"Staskin","year":"2009","journal-title":"J Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513114000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513114000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:38:52Z","timestamp":1761485932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513114000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1477513114000205"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2013.12.017","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single center experience with oxybutynin transdermal system (patch) for management of symptoms related to non-neuropathic overactive bladder in children: An attractive, well tolerated alternative form of administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2013.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}